Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts

References

• Hoffman HM, Mueller JL, Broide DH, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome. Nat Genet 2001;29:301-5
   PubMed Web of Science ®Google Scholar
• Manji GA, Wang L, Geddes BJ, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 2002;277:11570-5
   PubMed Web of Science ®Google Scholar
• Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46:2445-52
   PubMed Web of Science ®Google Scholar
• Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003;4:95-104
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8:279-89
   PubMed Web of Science ®Google Scholar
• Vladimer GI, Marty-Roix R, Ghosh S, et al. Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol 2013;16:23-31
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147
   PubMed Web of Science ®Google Scholar
• Chen M, Wang H, Chen W, et al. Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol 2011;11:549-54
   Google Scholar
• Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 2004;20:319-25
   PubMed Web of Science ®Google Scholar
• Janssen R, Verhard E, Lankester A, et al. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2004;50:3329-33
   PubMed Web of Science ®Google Scholar
• Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 2013;25:469-84
   PubMed Web of Science ®Google Scholar
• Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med 2014;65:223-44
   PubMed Web of Science ®Google Scholar
• Federici S, Martini A, Gattorno M. The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol 2013;4:351
   Google Scholar
• Koné-Paut I, Galeotti C. Anakinra for cryopyrin-associated periodic syndrome. Expert Rev Clin Immunol 2014;10:7-18
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lopalco G, Caso F, et al. Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet’s disease. Autoimmun Rev 2015;14:1-9
   PubMed Web of Science ®Google Scholar
• Scarpioni R, Rigante D, Cantarini L, et al. Renal involvement in secondary amyloidosis of Muckle–Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Clin Rheumatol 2014. [Epub ahead of print]
   Google Scholar
• Kapur S, Bonk ME. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes. P T Peer-Rev J Formul Manag 2009;34:138-41
   Google Scholar
• Cuisset L, Jeru I, Dumont B, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis 2011;70:495-9
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Gregory SG, Mueller JL, et al. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet 2003;112:209-16
   PubMed Web of Science ®Google Scholar
• Aróstegui JI, Aldea A, Modesto C, et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004;50:4045-50
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002;46:3340-8
   PubMed Web of Science ®Google Scholar
• Aróstegui JI, Lopez Saldaña MD, Pascal M, et al. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying Mendelian inherited diseases. Arthritis Rheum 2010;62:1158-66
   PubMedGoogle Scholar
• Nakagawa K, Gonzalez-Roca E, Souto A, et al. Somatic NLRP3 mosaicism in Muckle–Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes. Ann Rheum Dis 2015;74:603-10
   PubMed Web of Science ®Google Scholar
• Saito M, Nishikomori R, Kambe N, et al. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood 2008;111:2132-41
   PubMed Web of Science ®Google Scholar
• Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum 2011;63:3625-32
   PubMed Web of Science ®Google Scholar
• Jiménez-Treviño S, González-Roca E, Ruiz-Ortiz E, et al. First report of vertical transmission of a somatic NLRP3 mutation in cryopyrin-associated periodic syndromes. Ann Rheum Dis 2013;72:1109-10
   PubMed Web of Science ®Google Scholar
• Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis 2014; Epub ahead of print
   Google Scholar
• Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol 2008;33:1-9
   PubMed Web of Science ®Google Scholar
• Yu JR, Leslie KS. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep 2011;11:12-20
   PubMed Web of Science ®Google Scholar
• Kolivras A, Theunis A, Ferster A, et al. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement. J Cutan Pathol 2011;38:202-8
   Google Scholar
• Kile RL, Rusk HA. A case of cold urticaria with an unusual family history. J Am Med Assoc 1940;114:1067-8
   Google Scholar
• Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2011;108:615-20
   Google Scholar
• Hull KM, Shoham N, Chae JJ, et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003;15:61-9
   PubMed Web of Science ®Google Scholar
• Goldfinger S. The inherited autoinflammatory syndrome: a decade of discovery. Trans Am Clin Climatol Assoc 2009;120:413-18
   PubMedGoogle Scholar
• Federici S, Gattorno M. A practical approach to the diagnosis of autoinflammatory diseases in childhood. Best Pract Res Clin Rheumatol 2014;28:263-76
   Google Scholar
• Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235-48
   PubMedGoogle Scholar
• Kuemmerle-Deschner JB, Koitschev A, Ummenhofer K, et al. Hearing loss in Muckle–Wells syndrome. Arthritis Rheum 2013;65:824-31
   Google Scholar
• Stew BT, Fishpool SJ, Owens D, et al. Muckle–Wells syndrome: a treatable cause of congenital sensorineural hearing loss. B-ENT 2013;9:161-3
   PubMed Web of Science ®Google Scholar
• Ahmadi N, Brewer CC, Zalewski C, et al. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg 2011;145:295-302
   PubMedGoogle Scholar
• Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12
   PubMed Web of Science ®Google Scholar
• Wirths G, Grenzebach U, Eter N. [Papillary edema in Muckle–Wells syndrome.]. Ophthalmol Z Dtsch Ophthalmol Ges 2015. [Epub ahead of print]
   Google Scholar
• Alejandre N, Ruiz-Palacios A, García-Aparicio AM, et al. Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation. Rheumatol Oxf Engl 2014;53:1095-9
   Google Scholar
• Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr 1981;99:79-83
   PubMed Web of Science ®Google Scholar
• Prieur AM, Griscelli C, Lampert F. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl 1987;66:57-68
   PubMedGoogle Scholar
• Goldbach-Mansky R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Rep 2011;13:123-31
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355:581-92
   PubMed Web of Science ®Google Scholar
• Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203
   PubMed Web of Science ®Google Scholar
• Hill SC, Namde M, Dwyer A, et al. Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr Radiol 2007;37:145-52
   PubMed Web of Science ®Google Scholar
• Torbiak RP, Dent PB, Cockshott WP. NOMID--a neonatal syndrome of multisystem inflammation. Skeletal Radiol 1989;18:359-64
   PubMedGoogle Scholar
• Neven B, Callebaut I, Prieur AM, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004;103:2809-15
   PubMed Web of Science ®Google Scholar
• Wang L, Manji GA, Grenier JM, et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 2002;277:29874-80
   PubMed Web of Science ®Google Scholar
• Infevers. Available from: http://fmf.igh.cnrs.fr/ISSAID/infevers/ [Last accessed 11 December 2015]
   Google Scholar
• Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008;29:803-8
   PubMed Web of Science ®Google Scholar
• Sarrauste de Menthière C, Terrière S, Pugnère D, et al. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 2003;31:282-5
   PubMed Web of Science ®Google Scholar
• Touitou I, Lesage S, McDermott M, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004;24:194-8
   PubMed Web of Science ®Google Scholar
• Frenkel J, van Kempen MJA, Kuis W, van Amstel HKP. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1. Arthritis Rheum 2004;50:2719-20
   Google Scholar
• Matsubayashi T, Sugiura H, Arai T, et al. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Acta Paediatr Oslo Nor 2006;95:246-9
   PubMed Web of Science ®Google Scholar
• Jéru I, Hayrapetyan H, Duquesnoy P, et al. PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: role of PYPAF1 in inflammation. Arthritis Rheum 2006;54:508-14
   PubMedGoogle Scholar
• Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 2012;71:1599-605
   PubMed Web of Science ®Google Scholar
• Vitale A, Lucherini OM, Galeazzi M, et al. Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol 2012;30:943-6
   PubMedGoogle Scholar
• Verma D, Särndahl E, Andersson H, et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production. PLoS One 2012;7:e34977
   Web of Science ®Google Scholar
• Rowczenio DM, Trojer H, Russell T, et al. Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature. Arthritis Res Ther 2013;15:R30
   PubMed Web of Science ®Google Scholar
• Cantarini L, Vitale A, Lucherini OM, et al. The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol 2015;34:17-28
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Iacoponi F, et al. Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol 2010;23:1133-41
   PubMed Web of Science ®Google Scholar
• Rieber N, Gavrilov A, Hofer L, et al. A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants. Clin Immunol Orlando Fla 2015;157:56-64
   Google Scholar
• Saito M, Fujisawa A, Nishikomori R, et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005;52:3579-85
   PubMedGoogle Scholar
• Omoyinmi E, Melo Gomes S, Standing A, et al. Brief Report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheumatol Hoboken NJ 2014;66:197-202
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, D Putnam C, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007;56:1273-85
   PubMed Web of Science ®Google Scholar
• Jéru I, Duquesnoy P, Fernandes-Alnemri T, et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA 2008;105:1614-19
   PubMed Web of Science ®Google Scholar
• Vitale A, Rigante D, Maggio MC, et al. Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol 2013;31:155-6
   PubMed Web of Science ®Google Scholar
• Vitale A, Rigante D, Lucherini OM, et al. The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. Clin Exp Rheumatol 2014;32:994
   Google Scholar
• De Pieri C, Vuch J, Athanasakis E, et al. F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. Clin Exp Rheumatol 2014;32:993-4
   PubMed Web of Science ®Google Scholar
• Ter Haar N, Lachmann H, Özen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013;72:678-85
   PubMed Web of Science ®Google Scholar
• Schnitzler L, Schubert B, Verret JL, et al. Cutaneous manifestations in disseminated intravascular coagulation syndrome. Ann Dermatol Syphiligr (Paris) 1976;103:124-34
   Google Scholar
• Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis 2010;5:38
   PubMed Web of Science ®Google Scholar
• De Koning HD, van Gijn ME, Stoffels M, et al. Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome. J Allergy Clin Immunol 2015;135:561-564.e4
   PubMed Web of Science ®Google Scholar
• Kitamura A, Sasaki Y, Abe T, et al. An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med 2014;211:2385-96
   PubMed Web of Science ®Google Scholar
• Gattorno M, Martini A. Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence. Arthritis Rheum 2013;65:1137-47
   PubMed Web of Science ®Google Scholar
• Tan MS, Yu JT, Jiang T, et al. NLRP3 polymorphisms are associated with late-onset Alzheimer’s disease in Han Chinese. J Neuroimmunol 2013;265:91-5
   PubMed Web of Science ®Google Scholar
• Tan MS, Yu JT, Jiang T, et al. The NLRP3 inflammasome in Alzheimer’s disease. Mol Neurobiol 2013;48:875-82
   PubMed Web of Science ®Google Scholar
• Yüksel Ş, Eren E, Hatemi G, et al. Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behçet’s syndrome patients. Int Immunol 2014;26:71-81
   Google Scholar
• Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41
   PubMed Web of Science ®Google Scholar
• Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-26
   PubMed Web of Science ®Google Scholar
• Touitou I, Perez C, Dumont B, et al. Refractory auto-inflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome mutations. Ann Rheum Dis 2006;65:1530-1
   PubMed Web of Science ®Google Scholar